Targeted therapies represent a significant advancement in cancer treatment. Unlike traditional chemotherapy, which attacks all rapidly dividing cells, targeted therapies specifically attack cancer cells by interfering with molecules involved in tumor growth and progression. This reduces damage to normal cells and minimizes side effects. Examples of targeted therapies include monoclonal antibodies and small molecule inhibitors. These therapies have shown promise in treating cancers that were previously difficult to manage, such as certain types of lung and breast cancer.
